Empagliflozin Prescribing at WIGHT PRIMARY PARTNERSHIPS LTD
Drugs used in diabetes | Endocrine System
Items (12m)
885
Total Quantity
29.3K
NHS Cost
£36.4K
vs National Avg
+41.4%
WIGHT PRIMARY PARTNERSHIPS LTD prescribed 885 items of Empagliflozin over the last 12 months at a cost of £36,416 to the NHS. This is 41.4% above the national average prescribing rate. Empagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jul 2026
70
Jul 2026
64
Jul 2026
82
Jul 2026
83
Jul 2026
63
Jul 2026
78
Jul 2026
67
Jul 2026
80
Jul 2026
71
Jul 2026
71
Jul 2026
78
Jul 2026
78
Prescribing Details
| Total Items | 885 |
|---|---|
| Total Quantity | 29,323 |
| Total NHS Cost | £36,416 |
| Presentations | 2 different forms |
| vs National Average | +41.4% |
Empagliflozin Prescribing Comparison
| This practice | 885 items |
|---|---|
| National average per practice | 626 items |
| Difference | +41.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.